24 Hrs
Source:
بوابة الشروق
Rep. El-Bayoumi Criticizes New Drug Pricing
The article discusses MP Samir Elyoumi's criticism of the Egyptian Drug Authority's decision regarding the new drug pricing mechanism. He considers that this decision conflicts with the Egyptian Constitution and affects citizens' right to access healthcare. He explained that relying on exchange rates, inflation, and interest rates to determine drug prices places a significant financial burden on vulnerable groups, especially the elderly and those with chronic illnesses, who often suffer from low income and an increasing need for medications. He noted that 70-80% of medication consumers are pensioners and pointed out that the authority did not take citizens' income into account when linking drug prices to these factors. Additionally, he submitted a supplementary question about how the decision violates the constitution and negatively impacts citizens' right to health, highlighting that the price change percentage depends on the exchange rate by 60%, which threatens the stability of drug prices and exacerbates the hardship faced by the most needy.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)